Resmed (Germany) Market Value
RMEA Stock | EUR 21.80 0.20 0.93% |
Symbol | Resmed |
Resmed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Resmed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Resmed.
04/21/2025 |
| 07/20/2025 |
If you would invest 0.00 in Resmed on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding Resmed Inc DRC or generate 0.0% return on investment in Resmed over 90 days. Resmed is related to or competes with Host Hotels, BRAEMAR HOTELS, Xenia Hotels, THAI BEVERAGE, Suntory Beverage, PPHE HOTEL, and Wyndham Hotels. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that ... More
Resmed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Resmed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Resmed Inc DRC upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.98 | |||
Information Ratio | 0.0663 | |||
Maximum Drawdown | 12.21 | |||
Value At Risk | (2.18) | |||
Potential Upside | 2.23 |
Resmed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Resmed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Resmed's standard deviation. In reality, there are many statistical measures that can use Resmed historical prices to predict the future Resmed's volatility.Risk Adjusted Performance | 0.14 | |||
Jensen Alpha | 0.187 | |||
Total Risk Alpha | (0) | |||
Sortino Ratio | 0.06 | |||
Treynor Ratio | 0.5204 |
Resmed Inc DRC Backtested Returns
Resmed appears to be very steady, given 3 months investment horizon. Resmed Inc DRC maintains Sharpe Ratio (i.e., Efficiency) of 0.18, which implies the firm had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Resmed Inc DRC, which you can use to evaluate the volatility of the company. Please evaluate Resmed's Coefficient Of Variation of 691.01, semi deviation of 1.28, and Risk Adjusted Performance of 0.14 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Resmed holds a performance score of 14. The company holds a Beta of 0.48, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Resmed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Resmed is expected to be smaller as well. Please check Resmed's sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to make a quick decision on whether Resmed's historical price patterns will revert.
Auto-correlation | 0.15 |
Insignificant predictability
Resmed Inc DRC has insignificant predictability. Overlapping area represents the amount of predictability between Resmed time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Resmed Inc DRC price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Resmed price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.15 | |
Spearman Rank Test | 0.41 | |
Residual Average | 0.0 | |
Price Variance | 0.03 |
Resmed Inc DRC lagged returns against current returns
Autocorrelation, which is Resmed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Resmed's stock expected returns. We can calculate the autocorrelation of Resmed returns to help us make a trade decision. For example, suppose you find that Resmed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Resmed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Resmed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Resmed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Resmed stock over time.
Current vs Lagged Prices |
Timeline |
Resmed Lagged Returns
When evaluating Resmed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Resmed stock have on its future price. Resmed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Resmed autocorrelation shows the relationship between Resmed stock current value and its past values and can show if there is a momentum factor associated with investing in Resmed Inc DRC.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Resmed Stock
Resmed financial ratios help investors to determine whether Resmed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resmed with respect to the benefits of owning Resmed security.